Table 2.
Activation (mV) |
Steady-state fast inactivation (mV) |
Use dependence (20 Hz) |
|||||||
---|---|---|---|---|---|---|---|---|---|
Nav1.7 | Drug | V1/2 | k | n | V1/2 | k | n | Percent | n |
WT | DMSO | –18.6 ± 0.8 | 8.2 ± 0.3 | 15 | –87.3 ± 1.3 | 6.8 ± 0.2 | 15 | 78.5% ± 1.5 | 15 |
CBZ | –20.2 ± 1.0 | 7.8 ± 0.2 | 12 | –89.9 ± 1.5 | 7.1 ± 0.2 | 11 | 70.0% ± 1.7* | 12 | |
V810M | DMSO | –20.9 ± 0.5 | 7.8 ± 0.2 | 15 | –87.8 ± 1.4 | 6.5 ± 0.2 | 14 | 77.1% ± 1.7 | 14 |
CBZ | –21.5 ± 0.8 | 7.5 ± 0.3 | 13 | –88.1 ± 1.9 | 6.8 ± 0.2 | 13 | 70.7% ± 1.6* | 12 |
Note: CBZ: carbamazepine; DMSO: dimethyl sulfoxide.
*p < 0.01 significantly different from DMSO; n represents the number of cells from which recordings were acquired.